Sep 11, 2023 / 02:00PM GMT
Terence C. Flynn - Morgan Stanley, Research Division - Equity Analyst
Great. Well, thanks for joining us, everybody. I'm Terence Flynn, the U.S. biopharma analyst at Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
With that out of the way, we're very pleased to have Editas joining us this morning. Today from the company, we have Gilmore O'Neill, who is President and CEO; and Baisong Mei, who is Senior Vice President and Chief Medical Officer. Thank you both so much for being here today.
Questions and Answers:
Terence C. Flynn - Morgan Stanley, Research Division - Equity AnalystMaybe to start us off, just kind of a high-level question here. Back earlier this year, you announced plans to reprioritize the company's pipeline. Maybe just give us an update